SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+6.89%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$491M
AUM Growth
+$491M
(+25%)
Cap. Flow
+$65.6M
Cap. Flow
% of AUM
13.37%
Top 10 Holdings %
Top 10 Hldgs %
36.88%
Holding
146
New
36
Increased
29
Reduced
18
Closed
21
Top Buys
| 1 |
GSK
GSK
|
$19.4M |
| 2 |
Gilead Sciences
GILD
|
$16.3M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$12.2M |
| 4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$8.71M |
| 5 |
TSRO
TESARO, Inc.
TSRO
|
$7.69M |
Top Sells
| 1 |
SHPG
Shire pic
SHPG
|
$24.1M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$7.09M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$5.52M |
| 4 |
CBIO
Crescent Biopharma, Inc. Common Stock
CBIO
|
$5.08M |
| 5 |
Novartis
NVS
|
$4.39M |
Sector Composition
| 1 | Healthcare | 79.26% |
| 2 | Technology | 7.56% |
| 3 | Industrials | 3.16% |
| 4 | Communication Services | 2.73% |
| 5 | Financials | 1.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGEN
76
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.86M | 0.32% | 36,000 | – | – |
|
|
MRNS
77
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1.82M | 0.31% | 1,331,421 | – | – |
|
78
TJX Companies
TJX
$152B
| $1.78M | 0.3% | 24,700 +2,000 | +9% | +$144K |
|
79
Ardelyx
ARDX
$1.53B
| $1.76M | 0.3% | 345,000 | – | – |
|
80
ProQR Therapeutics
PRQR
$237M
| $1.72M | 0.29% | 330,000 | – | – |
|
81
Sapiens International
SPNS
$2.4B
| $1.65M | 0.28% | 147,306 | – | – |
|
|
AKAO
82
DELISTED
Achaogen, Inc.
AKAO
| $1.63M | 0.28% | 75,000 -125,000 | -63% | -$2.72M |
|
83
Tower Semiconductor
TSEM
$6.58B
| $1.6M | 0.27% | 67,155 | – | – |
|
84
Summit Therapeutics
SMMT
$17.6B
| $1.56M | 0.27% | 142,018 -5,432 | -4% | -$59.7K |
|
85
Flex
FLEX
$20.1B
| $1.54M | 0.26% | +94,500 | New | +$1.54M |
|
86
PDS Biotechnology
PDSB
$57.8M
| $1.54M | 0.26% | 150,000 | – | – |
|
87
Wabtec
WAB
$33.1B
| $1.52M | 0.26% | +16,600 | New | +$1.52M |
|
88
vTv Therapeutics
VTVT
| $1.49M | 0.25% | 300,000 | – | – |
|
89
MacroGenics
MGNX
$112M
| $1.42M | 0.24% | 81,200 | – | – |
|
90
Mastercard
MA
$538B
| $1.4M | 0.24% | 11,525 | – | – |
|
|
RNTX
91
Rein Therapeutics, Inc. Common Stock
RNTX
$32M
| $1.39M | 0.24% | +125,000 | New | +$1.39M |
|
92
Evoke Pharma
EVOK
$8.49M
| $1.28M | 0.22% | 500,000 | – | – |
|
93
Kornit Digital
KRNT
$669M
| $1.11M | 0.19% | 57,300 +56,400 | +6,267% | +$1.09M |
|
|
XLRN
94
DELISTED
Acceleron Pharma Inc.
XLRN
| $1.06M | 0.18% | 35,000 -65,000 | -65% | -$1.98M |
|
95
VistaGen Therapeutics
VTGN
$102M
| $1.02M | 0.17% | 544,100 | – | – |
|
96
Neurogene
NGNE
$264M
| $874K | 0.15% | +62,085 | New | +$874K |
|
97
Verisk Analytics
VRSK
$37.5B
| $793K | 0.13% | +9,400 | New | +$793K |
|
98
Rocket Pharmaceuticals
RCKT
$354M
| $763K | 0.13% | 401,764 | – | – |
|
99
Xenon Pharmaceuticals
XENE
$2.98B
| $718K | 0.12% | 228,029 -100,000 | -30% | -$315K |
|
|
VIRX
100
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $522K | 0.09% | 193,212 +68,212 | +55% | +$184K |
|